Upcoming Events
Log In
Pricing
Free Trial

Case Review: Utilizing the Leikert Grading System

HIDE
PrevNext

0:00

Okay, we've got a 61-year-old man

0:02

with an elevated PSA of 5.19 recently.

0:08

4 00:00:09,300 --> 00:00:14,850 But there's a history of two negative biopsies,

0:15

and the overall gland volume of 55.4

0:20

yields a PSA density of

0:24

0.09 nanograms per ml per cc.

0:29

So, a very low PSA density.

0:33

So, we've got a lot of factors swirling around us

0:37

that point us away from the diagnosis of cancer.

0:41

And that could potentially

0:42

influence how we attack this lesion.

0:46

So here's an axial T2.

0:48

I'll scroll a little bit just

0:49

to give you a feel for it.

0:51

And some of you may see the lesion right away,

0:53

others may not, but here it is right there.

0:58

And there is a little bit of diffusion

1:01

restriction, here it is right there.

1:03

And that's going to make most of you nervous.

1:06

So, the amount of diffusion restriction is

1:09

mild, as you can see from the intensity, or lack

1:13

thereof, on the high B-value diffusion image.

1:17

The hypointensity is not that profound on

1:20

the ADC map, so you probably would go with the

1:26

see-saw in-between tweener PIRADS 3, or not.

1:33

The original reader went with a PIRADS 3.

1:38

But let's talk about another way

1:40

to approach lesions like this.

1:43

We're going to talk about the Likert

1:44

grading system, which one of my Aussie

1:47

colleagues has informed me is analogous to,

1:49

you know, hotel grading on TripAdvisor.

1:53

So let's see.

1:55

What's a, what's a Likert 1?

1:57

A Likert 1 would be no cancer.

2:02

A Likert 2 would be normal, with some

2:07

abnormalities present that are not cancer.

2:11

A Likert 3 would be possibly cancer.

2:16

A Likert 4 would be probably cancer.

2:20

And a Likert 5 would be cancer.

2:23

Now you're saying to yourself, Okay, how is this

2:26

any different than the PIRADS grading system?

2:29

Well, you know, when you walk into a hotel,

2:31

and you see all the pretty chandeliers,

2:34

and you have a beautiful room, you

2:36

say, okay, well that is a 5-star hotel.

2:40

But what if the food is lousy?

2:42

What if the service is bad?

2:45

What if the beaches are smelly?

2:48

You haven't incorporated all the

2:50

factors that go into making it a

2:54

really superior venue to vacation.

2:58

And that's kind of what the

2:59

Likert system is all about.

3:01

It's not just about the strict PIRADS criteria.

3:07

It may be about how much

3:09

diffusion restriction you have.

3:12

What the PSA rise has been.

3:15

What the PSA density is, where the lesion

3:19

is located, just how encapsulated is it,

3:23

are there microcysts, and innumerable

3:27

other indirect signs that you might

3:29

use to assist you in your diagnosis.

3:32

For instance, you know that in this area up

3:36

front right here, it's a very dangerous area.

3:39

So you might be more aggressive in

3:42

that area with extreme diffusion

3:45

restriction than you might be otherwise.

3:49

Or if you get up high near the central zone,

3:52

where things are very gray and intermediate.

3:56

Let's go up high in the central zone area.

4:00

You know, you're looking more for symmetry

4:02

between the two sides to make a decision.

4:05

Since signal intensities can be

4:08

very amorphous in this location.

4:10

So you're using the entirety of your experience.

4:14

The compendium of your experience both

4:16

visually and all of the clinical factors

4:21

that will push you one way or another

4:23

and improve your odds of being right.

4:26

So the Likert system is more comprehensive.

4:29

Both visually, intellectually, and clinically.

4:34

So, in this particular instance,

4:36

we might say, okay, we've got a little

4:38

nodule abutting the capsule on the left.

4:41

It has some diffusion restriction.

4:44

The ADC map characteristics aren't that strong.

4:46

And when I go to my diffuse,

4:49

to my DCE MRI, let's go there.

4:53

It doesn't look any different than anything else.

4:55

There's no hypervascularity.

4:57

Okay.

4:58

So because we have two negative biopsies and we

5:01

got a low PSA density, I would go with a Likert

5:06

2 and I would follow this one up in a year.

5:10

Plus again, the patient has

5:11

already had two negative biopsies.

5:13

And negative biopsies beget more negative

5:17

biopsies just like they do in the breast.

5:22

Now let's take another caveat.

5:24

Let's take the reverse.

5:26

We have this tweener lesion here.

5:28

A little bit of diffusion restriction.

5:30

But let's say the vascularity was,

5:34

was pretty bright right in this location.

5:37

So now we would say, okay, it's a PI-RADS 3,

5:39

but now we have hypervascularity.

5:43

We're going to use the DCE,

5:45

Dynamic Contrast-Enhanced MRI, to add 3 plus 1

5:50

to give us the equivalent of a 4.

5:55

So we're using the DCE MRI to

5:58

upgrade, or upgrade our nodule.

6:01

Now that didn't happen here.

6:03

But, I'm giving you a hypothetical circumstance.

6:07

Now, a 3 plus 1 in this scenario is not

6:10

as strong as a true PI-RADS 4,

6:14

where you've got a nodule that's under

6:16

1.5 centimeters, and the diffusion restriction

6:20

is really intense, and the ADC is really black.

6:25

That would be a much stronger scenario,

6:27

or a stronger scenario, and more

6:29

likely to have a higher Gleason grade.

6:32

Then this 3 plus 1 scenario,

6:34

which is equivalent to a 4.

6:38

So this case, originally read as a Pirates 3,

6:41

but downgraded, or downbraided, as a

6:46

Likert 2 for all the reasons mentioned. ChatGPT 121 00:06:25,170 --> 00:06:27,030 That would be a much stronger scenario,

6:27

or a stronger scenario, and more

6:29

likely to have a higher Gleason grade.

6:32

Than this 3 plus 1 scenario,

6:34

which is equivalent to a 4.

6:38

So this case, originally read as a PI-RADS 3,

6:41

but downgraded, or downgraded,

6:46

as a Likert 2 for all the reasons mentioned.

Report

Faculty

Stephen J Pomeranz, MD

Chief Medical Officer, ProScan Imaging. Founder, MRI Online

ProScan Imaging

Tags

Prostate/seminal vesicles

Non-infectious Inflammatory

Neoplastic

MRI

Genitourinary (GU)

Body